SCHEMBL2445194

SCHEMBL2445194

O/N=C\c1ccc(Cl)c2cccnc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.57
▸ HSP90AA1 P07900 5/20 0.57
▸ MAPT P10636 5/20 0.57
▸ LMNA P02545 4/20 0.57
▸ METAP2 P50579 2/20 0.57
▸ METAP1 P53582 2/20 0.57
▸ BRD4 O60885 1/20 0.57
▸ ALDH1A1 P00352 7/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ CYP3A4 P08684 3/20 0.47
▸ ALOX12 P18054 3/20 0.47
▸ TDP1 Q9NUW8 3/20 0.47
▸ MMP14 P50281 3/20 0.47
▸ HTT P42858 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ SLC6A2 P23975 2/20 0.47
▸ OPRK1 P41145 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445195 1.00 KDM4E (0.57) KDM4EHSP90AA1MAPTLMNAMETAP2
SCHEMBL16643739 0.82 KMT2A (0.50) KDM4EHSP90AA1MAPTLMNAMETAP2
SCHEMBL18980187 0.82 KMT2A (0.50) KDM4EHSP90AA1MAPTLMNAMETAP2
SCHEMBL196536 0.76 KDM4E (0.70) KDM4EHSP90AA1MAPTLMNAMETAP2
SCHEMBL1036680 0.75 KDM4E (0.44) KDM4EHSP90AA1MAPTLMNABRD4
SCHEMBL1036682 0.75 KDM4E (0.44) KDM4EHSP90AA1MAPTLMNABRD4
SCHEMBL16962661 0.75 KDM4E (0.50) KDM4EHSP90AA1MAPTLMNAALDH1A1
SCHEMBL16962659 0.75 KDM4E (0.50) KDM4EHSP90AA1MAPTLMNAALDH1A1
SCHEMBL2161037 0.74 KDM4E (0.52) KDM4EHSP90AA1MAPTLMNAMETAP2
SCHEMBL2161036 0.74 KDM4E (0.52) KDM4EHSP90AA1MAPTLMNAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 — — EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 — — EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 — — EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 — — EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 — — EP disclosed
Send feedback